The effects of CX3CL1/ICAM-1 on NSCLC spinal metastasis in vivo were validated using bioluminescent, micro-computerized tomography, immunohistochemistry and histological analyses. The gene discussed is CX3CL1; the disease is non-small cell lung carcinoma.